168 related articles for article (PubMed ID: 32385316)
1. Nephrectomy Does not Exacerbate Cancellous Bone loss in Thalassemic Mice.
Lotinun S; Atjanasuppat K; Limsuvech J; Leelahavanichkul A; Svasti S; Krishnamra N
Sci Rep; 2020 May; 10(1):7786. PubMed ID: 32385316
[TBL] [Abstract][Full Text] [Related]
2. High phosphate intake induces bone loss in nephrectomized thalassemic mice.
Wanna-Udom S; Luesiripong C; Sakunrangsit N; Metheepakornchai P; Intharamonthian S; Svasti S; Greenblatt MB; Leelahavanichkul A; Lotinun S
PLoS One; 2022; 17(5):e0268732. PubMed ID: 35622784
[TBL] [Abstract][Full Text] [Related]
3. Responses of primary osteoblasts and osteoclasts from hemizygous β-globin knockout thalassemic mice with elevated plasma glucose to 1,25-dihydroxyvitamin D
Charoenphandhu N; Aeimlapa R; Sooksawanwit S; Thongbunchoo J; Teerapornpuntakit J; Svasti S; Wongdee K
Sci Rep; 2019 Sep; 9(1):13963. PubMed ID: 31562377
[TBL] [Abstract][Full Text] [Related]
4. Running exercise alleviates trabecular bone loss and osteopenia in hemizygous β-globin knockout thalassemic mice.
Thongchote K; Svasti S; Teerapornpuntakit J; Krishnamra N; Charoenphandhu N
Am J Physiol Endocrinol Metab; 2014 Jun; 306(12):E1406-17. PubMed ID: 24780610
[TBL] [Abstract][Full Text] [Related]
5. [The treatment effects and mechanisms of pyrroloquinoline quinone on defective teeth and mandible in Bmi-1 knockout mice].
Huang Y; Miao D; Chen N
Zhonghua Kou Qiang Yi Xue Za Zhi; 2015 Aug; 50(8):496-502. PubMed ID: 26702669
[TBL] [Abstract][Full Text] [Related]
6. 11β-HSD1 plays a critical role in trabecular bone loss associated with systemic glucocorticoid therapy.
Fenton CG; Doig CL; Fareed S; Naylor A; Morrell AP; Addison O; Wehmeyer C; Buckley CD; Cooper MS; Lavery GG; Raza K; Hardy RS
Arthritis Res Ther; 2019 Aug; 21(1):188. PubMed ID: 31420008
[TBL] [Abstract][Full Text] [Related]
7. Kit
Lotinun S; Suwanwela J; Poolthong S; Baron R
Calcif Tissue Int; 2018 Jan; 102(1):93-104. PubMed ID: 29032463
[TBL] [Abstract][Full Text] [Related]
8. Cathepsin K Deficiency Suppresses Disuse-Induced Bone Loss.
Moriya S; Izu Y; Arayal S; Kawasaki M; Hata K; Pawaputanon Na Mahasarakhahm C; Izumi Y; Saftig P; Kaneko K; Noda M; Ezura Y
J Cell Physiol; 2016 May; 231(5):1163-70. PubMed ID: 26460818
[TBL] [Abstract][Full Text] [Related]
9. Disparate effects of mild, moderate, and severe secondary hyperparathyroidism on cancellous and cortical bone in rats with chronic renal insufficiency.
Miller MA; Chin J; Miller SC; Fox J
Bone; 1998 Sep; 23(3):257-66. PubMed ID: 9737348
[TBL] [Abstract][Full Text] [Related]
10. Deletion of FoxO1, 3, and 4 in Osteoblast Progenitors Attenuates the Loss of Cancellous Bone Mass in a Mouse Model of Type 1 Diabetes.
Iyer S; Han L; Ambrogini E; Yavropoulou M; Fowlkes J; Manolagas SC; Almeida M
J Bone Miner Res; 2017 Jan; 32(1):60-69. PubMed ID: 27491024
[TBL] [Abstract][Full Text] [Related]
11. Relative comparison of chronic kidney disease-mineral and bone disorder rat models.
Zhang X; Li T; Wang L; Li Y; Ruan T; Guo X; Wang Q; Meng X
Front Physiol; 2023; 14():1083725. PubMed ID: 36818435
[No Abstract] [Full Text] [Related]
12. Effects of vitamin K2 on cortical and cancellous bone mass, cortical osteocyte and lacunar system, and porosity in sciatic neurectomized rats.
Iwamoto J; Matsumoto H; Takeda T; Sato Y; Yeh JK
Calcif Tissue Int; 2010 Sep; 87(3):254-62. PubMed ID: 20556371
[TBL] [Abstract][Full Text] [Related]
13. Ovariectomy-induced bone loss in
Zhu S; He H; Gao C; Luo G; Xie Y; Wang H; Tian L; Chen X; Yu X; He C
J Mol Endocrinol; 2018 Apr; 60(3):185-198. PubMed ID: 29339399
[TBL] [Abstract][Full Text] [Related]
14. Loss of interleukin-10 exacerbates early Type-1 diabetes-induced bone loss.
Rios-Arce ND; Dagenais A; Feenstra D; Coughlin B; Kang HJ; Mohr S; McCabe LR; Parameswaran N
J Cell Physiol; 2020 Mar; 235(3):2350-2365. PubMed ID: 31538345
[TBL] [Abstract][Full Text] [Related]
15. Differential Modulation of Cancellous and Cortical Distal Femur by Fructose and Natural Mineral-Rich Water Consumption in Ovariectomized Female Sprague Dawley Rats.
Pereira C; Guede D; Durães C; Brandão I; Silva N; Passos E; Bernardes M; Monteiro R; Martins MJ
Nutrients; 2019 Sep; 11(10):. PubMed ID: 31574967
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of FGFR Signaling Partially Rescues Hypophosphatemic Rickets in HMWFGF2 Tg Male Mice.
Xiao L; Du E; Homer-Bouthiette C; Hurley MM
Endocrinology; 2017 Oct; 158(10):3629-3646. PubMed ID: 28938491
[TBL] [Abstract][Full Text] [Related]
17. A soluble activin type IIA receptor mitigates the loss of femoral neck bone strength and cancellous bone mass in a mouse model of disuse osteopenia.
Lodberg A; Eijken M; van der Eerden BCJ; Okkels MW; Thomsen JS; Brüel A
Bone; 2018 May; 110():326-334. PubMed ID: 29499419
[TBL] [Abstract][Full Text] [Related]
18. Osteoprotegerin and RANKL in the pathogenesis of thalassemia-induced osteoporosis: new pieces of the puzzle.
Morabito N; Gaudio A; Lasco A; Atteritano M; Pizzoleo MA; Cincotta M; La Rosa M; Guarino R; Meo A; Frisina N
J Bone Miner Res; 2004 May; 19(5):722-7. PubMed ID: 15068494
[TBL] [Abstract][Full Text] [Related]
19. Cannabidiol administration reduces sublesional cancellous bone loss in rats with severe spinal cord injury.
Li D; Lin Z; Meng Q; Wang K; Wu J; Yan H
Eur J Pharmacol; 2017 Aug; 809():13-19. PubMed ID: 28479140
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-6 gene knockout antagonizes high-fat-induced trabecular bone loss.
Wang C; Tian L; Zhang K; Chen Y; Chen X; Xie Y; Zhao Q; Yu X
J Mol Endocrinol; 2016 Oct; 57(3):161-70. PubMed ID: 27493246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
